Yogendra Kumar Gupta Selected Research

Yogendra Kumar Gupta Research Topics

Disease

21	Epilepsy (Aura) 10/2022 - 11/2004
16	Seizures (Absence Seizure) 10/2022 - 02/2006
11	Cognitive Dysfunction 12/2022 - 12/2009
9	Arthritis (Polyarthritis) 09/2017 - 04/2007
7	Stroke (Strokes) 06/2020 - 06/2002
7	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2018 - 06/2002
7	Inflammation (Inflammations) 01/2018 - 03/2005
5	Infarction (Infarctions) 01/2018 - 06/2002
5	Edema (Dropsy) 09/2017 - 01/2013
4	Ischemic Stroke 06/2020 - 01/2011
4	Body Weight (Weight, Body) 01/2019 - 11/2012
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2019 - 01/2017
3	Cerebral Infarction 01/2018 - 02/2017
3	Type 2 Diabetes Mellitus (MODY) 01/2018 - 12/2014
3	Granuloma 11/2016 - 01/2013
3	Dyslipidemias (Dyslipidemia) 01/2015 - 04/2012
3	Pain (Aches) 01/2012 - 03/2004
2	Multiple Myeloma 03/2024 - 12/2022
2	Alzheimer Disease (Alzheimer's Disease) 12/2022 - 01/2013
2	Status Epilepticus (Complex Partial Status Epilepticus) 10/2022 - 02/2006
2	Necrosis 06/2019 - 01/2016
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2019 - 01/2019
2	Neoplasms (Cancer) 09/2017 - 01/2016
2	Hypersensitivity (Allergy) 07/2017 - 05/2011
2	Brain Ischemia (Cerebral Ischemia) 02/2017 - 12/2011
2	Acute Kidney Injury (Acute Renal Failure) 07/2016 - 01/2016
2	Ischemia 06/2015 - 06/2002
2	Rheumatoid Arthritis 01/2015 - 04/2014
2	Hyperlipidemias (Hyperlipidemia) 12/2014 - 07/2013
2	Myoclonus (Nocturnal Myoclonus) 09/2011 - 11/2010
1	Peripheral Nervous System Diseases (PNS Diseases) 03/2024
1	Communicable Diseases (Infectious Diseases) 11/2023
1	Infections 11/2023
1	Atrophy 12/2022
1	Reperfusion Injury 06/2020
1	COVID-19 05/2020
1	Drug-Related Side Effects and Adverse Reactions 01/2020
1	Newborn Respiratory Distress Syndrome 01/2019

Drug/Important Bio-Agent (IBA)

17	Anticonvulsants (Antiepileptic Drugs)IBA 04/2021 - 10/2010
8	Valproic Acid (Depakote)FDA LinkGeneric 04/2021 - 09/2011
7	AntioxidantsIBA 06/2020 - 06/2002
7	Freund's AdjuvantIBA 09/2017 - 12/2010
7	Carbamazepine (Tegretol)FDA LinkGeneric 03/2016 - 12/2004
6	Phenytoin (Dilantin)FDA LinkGeneric 04/2021 - 12/2009
6	Pentylenetetrazole (Metrazol)IBA 04/2021 - 11/2010
6	CytokinesIBA 03/2016 - 03/2005
5	Neuroprotective AgentsIBA 01/2018 - 12/2011
5	CarrageenanIBA 09/2017 - 01/2013
5	LipidsIBA 03/2016 - 11/2012
4	EnzymesIBA 03/2024 - 12/2004
4	Streptozocin (Streptozotocin)FDA Link 12/2022 - 12/2012
4	Imatinib Mesylate (Gleevec)FDA Link 01/2019 - 01/2017
4	Formaldehyde (Formol)FDA Link 08/2016 - 12/2010
4	CurcuminIBA 09/2011 - 12/2009
3	Biomarkers (Surrogate Marker)IBA 12/2022 - 01/2017
3	Morphine (MS Contin)FDA LinkGeneric 10/2022 - 03/2004
3	Cisplatin (Platino)FDA LinkGeneric 06/2019 - 01/2016
3	Cholinesterases (Cholinesterase)IBA 12/2013 - 08/2011
3	Phenobarbital (Luminal)FDA Link 11/2012 - 10/2010
3	Malondialdehyde (Propanedial)IBA 11/2010 - 06/2002
2	Bortezomib (Velcade)FDA Link 03/2024 - 12/2022
2	Insulin (Novolin)FDA Link 12/2022 - 11/2012
2	lercanidipineIBA 06/2020 - 02/2017
2	goat lung surfactant extractIBA 01/2019 - 01/2019
2	diazonaphthalenedisulfonic acid (NDS)IBA 01/2018 - 02/2017
2	Cytochrome P-450 CYP3AIBA 06/2017 - 01/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2016 - 01/2013
2	CalciumIBA 04/2016 - 06/2015
2	Clobazam (HR 376)IBA 03/2016 - 08/2014
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 11/2015 - 01/2011
2	Sirolimus (Rapamycin)FDA Link 06/2015 - 12/2011
2	LDL Lipoproteins (beta Lipoproteins)IBA 01/2015 - 02/2013
2	Lipoproteins (Lipoprotein)IBA 01/2015 - 12/2014
2	PowdersIBA 01/2015 - 04/2012
2	Atorvastatin (Lipitor)FDA Link 12/2014 - 02/2013
2	arogya-wardhaniIBA 07/2013 - 04/2012
2	Tissue Plasminogen Activator (Alteplase)FDA Link 06/2012 - 01/2011
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 06/2012 - 12/2011
2	Tacrolimus (Prograf)FDA LinkGeneric 06/2012 - 12/2011
2	Glutathione (Reduced Glutathione)IBA 11/2010 - 06/2002
2	Free RadicalsIBA 10/2010 - 06/2002
2	MelatoninIBA 12/2004 - 11/2004
1	Cytochrome P-450 CYP2C19IBA 03/2024
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2023
1	Endoplasmic Reticulum Chaperone BiPIBA 12/2022
1	Glucose (Dextrose)FDA LinkGeneric 12/2022
1	Proteins (Proteins, Gene)FDA Link 12/2022
1	SodiumIBA 07/2020
1	Protons (Proton)IBA 06/2020
1	salicylhydroxamic acid (SHAM)IBA 06/2020
1	remdesivirIBA 05/2020
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 10/2019
1	beractant (Survanta)FDA Link 01/2019
1	APTIBA 01/2019
1	MetalsIBA 01/2019
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2019
1	Losartan (Cozaar)FDA LinkGeneric 01/2019

Therapy/Procedure

12	Therapeutics 03/2024 - 12/2004
3	Drug Therapy (Chemotherapy) 01/2022 - 09/2017
2	Injections 01/2013 - 04/2007